european commission press

All EU institutions, bodies and agencies have their own dedicated press services and contacts. ... Press release 12 January 2021. We'll assume you're ok with this, but you can opt-out if you wish. This press release contains certain forward-looking statements relating to the business of Valneva, including with respect to the progress, timing, design, data read-outs, anticipated results and completion of clinical trials for VLA2001. press release as PDF Website and Open Call STARTS Prize 2021 Photo album STARTS Prize 2020 Ars Electronica Blog (Linz/Brussels, 11 January, 2021) As of today, scientists, technologists, artists, institutions, labs and companies are invited once again to submit their best projects for the STARTS Prize 2021 of the European Commission. These cookies will be stored in your browser only with your consent. h.c. F. Porsche AG, a subsidiary of the Volkswagen group, and Schuler AG of the Andritz group, to build and operate a metal press plant in Germany. The Initiative aims to improve the protection of persons belonging to national and linguistic minorities. We are taking resolute action to reinforce our public health sectors and mitigate the socio-economic impact in the European Union. Launched end 2005, the European Jewish Press is the sole online Jewish news agency in Europe. Thomas Lingelbach, Chief Executive Officer of Valneva, said, “Today’s announcement helps to ensure that millions of Europeans potentially have access to a proven and well-established inactivated vaccine approach, upon approval of VLA2001. Corporate Communications Specialist Read more how the European Union and its member states are working around the clock to fight against the coronavirus (COVID-19). We are grateful to the European Commission for their support and eager to partner with them to address the ongoing pandemic. European Commission STREAMING SERVICE OF THE EUROPEAN COMMISSION. The main EU institutions each have a press room with facilities for journalists, where briefings and conferences are organised regularly. On January 8th 2021, a Data Safety Monitoring Board (DSMB) gave approval to progress into the study’s full randomization phase. The meeting focused in particular on progress achieved on negotiations on investment. This category only includes cookies that ensures basic functionalities and security features of the website. About VLA2001 These forward-looking statements are based on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievement expressed or implied by these forward-looking statements. You also have the option to opt-out of these cookies. Saint-Herblain (France), January 12, 2021 – Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.VLA2001 is currently the only … Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with over 500 employees. All official European Union website addresses are in the europa.eu domain.. See all EU institutions and bodies Laetitia Bachelot-Fontaine Here posts the Social Media Team. True believer in EU’s values. About VLA2001-201 Because of this, the European Union decided to propose emergency changes. The European Commission’s approval is based on the results of the SENSCIS ® trial, a Phase III, double-blind, placebo-controlled trial conducted to investigate the efficacy and safety of nintedanib in patients with SSc-ILD. European Commission President Ursula von der Leyen delivers a statement at EU headquarters in Brussels on Sunday. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Broadcast professionals have free access to the full range of audiovisual services provided by the European institutions. Journalists, film crews and photographers require accreditation in order to access the EU institution buildings. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. If clinical development is successful, an initial approval may be granted in the second half of 2021. Press contacts Contact spokesperson's and press officers of the European Commission as well as press officers in national EC representations Commission spokesperson's service Dedicated to innovation in vaccine research and development. T +43 (0)1 20620 1116 These cookies do not store any personal information. The future partnershipThe United Kingdom left the European Union on 31 January 2020, after 47 years of EU membership. Review recent and past Novartis healthcare news stories, including media releases and featured information. The European Commission has concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. About Valneva SE [1] Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine, [2] Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government. Upon analysis of the data, Valneva will select the best dose and commence the second part of the Phase 1/2 clinical development. Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. The press office holds press events, offers ... European Council President Charles Michel and European Commission President Ursula von der Leyen held a leaders’ meeting with China, represented by President Xi Jinping, via videoconference on 30 December 2020. 31 July 2020 – Alstom and Bombardier welcome the European Commission’s (EC) decision for conditional clearance of the proposed acquisition of Bombardier Transportation by Alstom.. The European Parliament and the European Commission also have press officers in each EU member country. Lee, supra note 3. VLA2001 entered Phase 1/2 clinical studies in December 2020[1] and Valneva expects to report initial safety and immunogenicity data in April 2021. We are deeply committed to providing broad access to our inactivated SARS-CoV-2 vaccine candidate and, as we proceed with clinical development, we will simultaneously continue working with partners, including the European Commission and the UK Government, to help us reach that goal. In particular, the expectations of Valneva could be affected by, among other things, uncertainties involved in the development and manufacture of vaccines, unexpected clinical trial results, unexpected regulatory actions or delays, competition in general, currency fluctuations, the impact of the global and European credit crisis, the ability to obtain or maintain patent or other proprietary intellectual property protection and the impact of the COVID-19 pandemic. Necessary cookies are absolutely essential for the website to function properly. The EU reached its current size of 28 member countries with the accession of Croatia on 1 July 2013. European Commission Press Release, supra note 1. The process, which has already been upscaled to final industrial scale, includes inactivation with BPL to preserve the native structure of the S-protein. ... Press release 8 January 2021. Valneva is providing the information in this press release as of the date hereof and disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. In some cases, you can identify forward-looking statements by words such as “could,” “should,” “may,” “expects,” “anticipates,” “believes,” “intends,” “estimates,” “aims,” “targets,” or similar words. Overall, 150 healthy young adults aged 18 to 55 years will be recruited. Representing the interests of the EU as a whole. Investor and Media Contacts We increasingly see wider recognition that our vaccine will be one that the world cannot do without.”. The European Commission has approved, under the EU Merger Regulation, the acquisition of Refinitiv by the London Stock Exchange Group (‘LSEG'). In addition, even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release, those results or developments of Valneva may not be indicative of future results. h.c. F. Porsche AG, a subsidiary of the Volkswagen group, and Schuler AG of the Andritz group, to build and operate a metal press … The study includes an open-label dose-escalation phase and will be conducted as a randomized, double-blind, multicenter study. European Commission - Press release State aid: Commission approves investment aid for Czech orchards and irrigations; opens in-depth investigations into Czech measures in favour of large agricultural companies Brussels, 12 January 2021 The European Commission has approved two Czech investment aid support schemes for the The European Commission is coordinating a common European response to the coronavirus outbreak. Zagreb. The press office holds press events, offers ... European Council President Charles Michel and European Commission President Ursula von der Leyen held a leaders’ meeting with China, represented by President Xi Jinping, via videoconference on 30 December 2020. VLA2001 is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe. We are taking resolute action to reinforce our public health sectors and mitigate the socio-economic impact in the European Union. It has been declared a pandemic by the World Health Organization (WHO). Under the partnership agreement, if vaccine development is successful, Valneva will provide the UK government with 60 million doses in the second half of 2021. SARS-CoV-2 is a new coronavirus identified in late 2019 and belongs to a family of enveloped RNA viruses that include MERS and SARS, both of which caused serious human infections of the respiratory system. The European Commission’s approval is based on the results of the SENSCIS ® trial, a Phase III, double-blind, placebo-controlled trial conducted to investigate the efficacy and safety of nintedanib in patients with SSc-ILD. The Commission’s approval for the transaction is conditional on the proposed engagements that consist of: A transfer of Bombardier Transportation’s contribution to the V300 ZEFIRO very high … The privately funded Brussels-based outlet is an independent media body. 28,590 talking about this. The European Commission (EC) is the executive branch of the European Union, responsible for proposing legislation, implementing decisions, upholding the EU treaties and managing the day-to-day business of the EU. Migrant Crisis: EU Plans Penalties for Refusing Asylum Seekers, supra note 5. M +33 (0)6 4516 7099 European Commission - Press release State aid: Commission approves investment aid for Czech orchards and irrigations; opens in-depth investigations into Czech measures in favour of large agricultural companies Brussels, 12 January 2021 The European Commission has approved two Czech investment aid support schemes for the In accordance with the Withdrawal Agreement, it is now officially a third country... European Data Protection Supervisor, Other bodies and agencies, European Securities and Markets Authority, Other bodies and agencies, Enlargement, external relations and trade, More information on accreditation procedures, Audiovisual facilities available at EU institutions, Read about EU institutions, agencies and decentralised bodies, Read more about EU member states and how to join the EU, European Citizens' Initiative: European Commission replies to ‘Minority Safepack' initiative, Communication on the European Citizens' Initiative 'Minority SafePack – one million signatures for diversity in Europe', ECI website: Minority SafePack – one million signatures for diversity in Europe, Coronavirus: Commission concludes exploratory talks with Valneva to secure a new potential vaccine, Questions and Answers on vaccine negotiations, Questions and Answers: Conditional marketing authorisation of COVID-19 vaccines, EU regions get additional 47.5 billion EUR to tackle local effects of COVID-19, Data for the public good: Building a healthier digital future, Links to the national websites explaining the procedures for notifications of net short positions, Weekly schedule of President Charles Michel, Media advisory - Informal video conference of European affairs ministers of 18 January 2021, Syrian foreign affairs minister added to EU sanctions list, Declaration by the High Representative on behalf of the European Union on the alignment of certain countries concerning restrictive measures against Belarus, Statement by President von der Leyen at the joint press conference with Prime Minister Costa on the occasion of the College visit to the Portuguese Presidency, Article - Coming up in plenary: vaccines, EU-US relations and Portuguese presidency. On July 5, 2018, the European Commission published a position paper launching several proposals to modernize the WTO and one of those addresses solutions to the Appellate Body’s nomination crisis. The virus, which causes a disease named COVID-19, has never before been found in humans. MEPs Press European Commission, Council, to Ratify Istanbul Convention. President of the European Commission Ursula von der Leyen takes off her protective face mask prior to speaking during a media conference at EU headquarters in Brussels, Thursday, Aug. 27, 2020. European Commission Press Release, supra note 1. Valneva’s vaccine candidate is based on a proven approach and will leverage the Company’s existing manufacturing platform being used for its US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approved Japanese encephalitis vaccine. 1 The primary endpoint was the annual rate of decline in forced vital capacity (FVC) assessed over a 52-week period. VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology for Valneva’s licensed Japanese encephalitis vaccine, IXIARO®. The EU has a unique institutional set-up where broad priorities are set by the European Council; decision-making involves European Parliament, Council of the EU and European Commission and number of other institutions. Valneva is a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need. The EU institutions and bodies offer numerous subscription services, ranging from the latest headlines to specialised publications. The main EU institutions each have a press room with facilities for journalists, where briefings and conferences are organised regularly. Following an evaluation of Part A data (i.e., data up to Day 36) from the present study, further clinical studies may be initiated. VLA2001 is Valneva’s vaccine candidate against the SARS-CoV-2 virus. This website uses cookies to improve your experience while you navigate through the website. Basic facts and figures on EU population and size, economy, employment levels and quality of life, and also some basic information about EU administration, its staff, languages and location. The meeting focused in particular on progress achieved on negotiations on investment. Publications of the University of Michigan Law School Faculty, 1859-includes published books, articles, book chapters, essays, introductions, forewords and book reviews written or edited by the University of Michigan Law faculty.For additional information see Persons and Materials Included and Excluded sections below. The European Commission is coordinating a common European response to the coronavirus outbreak. All EU institutions, bodies and agencies have their own dedicated press services and contacts. Forward-Looking Statements Lee, supra note 3. This website uses cookies to improve your experience. The official website of the European Commission, providing access to information about its political priorities, policies and services. Saint-Herblain (France), January 12, 2021 – Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is in advanced discussions with the European Commission (EC) for the supply of up to 60 million doses of its COVID-19 vaccine, VLA2001.
european commission press 2021